Login to Your Account



Search

Search results

U.S. Patent Disclosures

No Abstract (BioWorld Today, BioWorld-Today-2009-04-06) ...

BioWorld Today - Staff - 2009-04-06 00:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

No Abstract (BioWorld Today, BioWorld-Today-2000-04-18) ...

BioWorld Today - Staff - 2000-04-18 00:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

No Abstract (BioWorld Today, BioWorld-Today-2001-07-20) ...

BioWorld Today - Staff - 2001-07-20 00:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

No Abstract (BioWorld Today, BioWorld-Today-2002-06-27) ...

BioWorld Today - Staff - 2002-06-27 00:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

• Confometrx , of Palo Alto, Calif., was issued U.S. Patent No. 8,470,561, "GPCR comprising an IC2 insertion," related to G protein-coupled receptors (GPCRs) that have a stabilizing fusion in the second intracellular loop (IC2). ...

BioWorld Today - Staff - 2013-08-22 00:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

No Abstract (BioWorld Today, BioWorld-Today-2007-09-04) ...

BioWorld Today - Staff - 2007-09-04 00:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

• Fibrocell Science Inc. , of Exton, Pa., was issued a U.S. patent for Laviv (azficel-T), related to azficel-T fibroblast suspension, which is a treatment for moderate to severe nasolabial fold wrinkles in adults. (BioWorld-Today-2013- ...

BioWorld Today - Staff - 2013-07-11 00:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

• Galectin Therapeutics Inc. , of Norcross, Ga., was issued a U.S. Patent notice of issuance for 13/573,454, “Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.” ...

BioWorld Today - Staff - 2013-09-27 00:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

No Abstract (BioWorld Today, BioWorld-Today-2004-06-28) ...

BioWorld Today - Staff - 2004-06-28 00:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

• Immunomedics Inc. , of Morris Plains, N.J., was granted U.S. Patent No. 8,105,596, titled "Immunotherapy of B-cell malignancies using anti-CD22 antibodies." It covers therapeutic compositions comprising any combination of conjugated ...

BioWorld Today - Staff - 2012-03-01 01:00 - 0 comments - 0 attachments